BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27318613)

  • 1. French consensus procedure for assessing cognitive function in Parkinson's disease.
    Dujardin K; Auzou N; Lhommée E; Czernecki V; Dubois B; Fradet A; Maltete D; Meyer M; Pineau F; Schmitt E; Sellal F; Tison F; Vidal T; Azulay JP; Welter ML; Corvol JC; Durif F; Rascol O;
    Rev Neurol (Paris); 2016 Nov; 172(11):696-702. PubMed ID: 27318613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain-specific accuracy of the Montreal Cognitive Assessment subsections in Parkinson's disease.
    Hendershott TR; Zhu D; Llanes S; Poston KL
    Parkinsonism Relat Disord; 2017 May; 38():31-34. PubMed ID: 28215728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. French neuropsychological procedure consensus in epilepsy surgery.
    Brissart H; Planton M; Bilger M; Bulteau C; Forthoffer N; Guinet V; Hennion S; Kleitz C; Laguitton V; Mirabel H; Mosca C; Pécheux N; Pradier S; Samson S; Tramoni E; Voltzenlogel V; Denos M; Boutin M
    Epilepsy Behav; 2019 Nov; 100(Pt A):106522. PubMed ID: 31627076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan.
    Yu RL; Wu RM; Tai CH; Lin CH; Cheng TW; Hua MS
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1067-72. PubMed ID: 22749792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and Motor Aspects of Parkinson's Disease Associated with Dysphagia.
    Kim JS; Youn J; Suh MK; Kim TE; Chin J; Park S; Cho JW
    Can J Neurol Sci; 2015 Nov; 42(6):395-400. PubMed ID: 26551089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tools of the trade: a state of the art "How to Assess Cognition" in the patient with Parkinson's disease.
    Marras C; Tröster AI; Kulisevsky J; Stebbins GT
    Mov Disord; 2014 Apr; 29(5):584-96. PubMed ID: 24757108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profile of Parkinson's disease patients: a comparative study between early-onset and late-onset Parkinson's disease.
    Tang H; Huang J; Nie K; Gan R; Wang L; Zhao J; Huang Z; Zhang Y; Wang L
    Int J Neurosci; 2016; 126(3):227-34. PubMed ID: 26001202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease.
    Kelly VE; Johnson CO; McGough EL; Shumway-Cook A; Horak FB; Chung KA; Espay AJ; Revilla FJ; Devoto J; Wood-Siverio C; Factor SA; Cholerton B; Edwards KL; Peterson AL; Quinn JF; Montine TJ; Zabetian CP; Leverenz JB
    Parkinsonism Relat Disord; 2015 Jul; 21(7):692-7. PubMed ID: 25943529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in Parkinson's disease: Association between patient-reported and clinically measured outcomes.
    Mills KA; Mari Z; Pontone GM; Pantelyat A; Zhang A; Yoritomo N; Powers E; Brandt J; Dawson TM; Rosenthal LS
    Parkinsonism Relat Disord; 2016 Dec; 33():107-114. PubMed ID: 27733275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of Cognitive Decline in Parkinson's Disease.
    Roheger M; Kalbe E; Liepelt-Scarfone I
    J Parkinsons Dis; 2018; 8(2):183-193. PubMed ID: 29914040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale-2 in Parkinson's disease.
    Hendershott TR; Zhu D; Llanes S; Zabetian CP; Quinn J; Edwards KL; Leverenz JB; Montine T; Cholerton B; Poston KL
    Mov Disord; 2019 Feb; 34(2):285-291. PubMed ID: 30776152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the performance of the Montreal Cognitive Assessment in early stage Parkinson's disease.
    Kletzel SL; Hernandez JM; Miskiel EF; Mallinson T; Pape TL
    Parkinsonism Relat Disord; 2017 Apr; 37():58-64. PubMed ID: 28189463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of montreal cognitive assessment between patients with visual hallucinations and without visual hallucinations in Parkinson's disease.
    Chung EJ; Seok K; Kim SJ
    Clin Neurol Neurosurg; 2015 Mar; 130():98-100. PubMed ID: 25596487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State anxiety predicts cognitive performance in patients with Parkinson's disease.
    Ehgoetz Martens KA; Silveira CRA; Intzandt BN; Almeida QJ
    Neuropsychology; 2018 Nov; 32(8):950-957. PubMed ID: 30284873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everyday functioning of people with Parkinson's disease and impairments in executive function: a qualitative investigation.
    Kudlicka A; Hindle JV; Spencer LE; Clare L
    Disabil Rehabil; 2018 Oct; 40(20):2351-2363. PubMed ID: 28597694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for the Neuropsychological Assessment of Patients with Parkinson's Disease].
    Liepelt-Scarfone I; Gräber S; Kalbe E; Riedel O; Ringendahl H; Schmidt N; Witt K; Roeske S
    Fortschr Neurol Psychiatr; 2021 Jul; 89(7-08):363-373. PubMed ID: 33561875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.